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Original Research Paper
Quality of life in multiple sclerosis: The
differential impact of motor and cognitive fatigue
Sabina David Ruban , Claudia Christina Hilt and Thor Petersen
Abstract
Background: Multiple sclerosis is a chronic disease leading to reduced quality of life.
Objectives: To investigate whether motor and cognitive fatigue impact differently on aspects of quality
of life among patients with multiple sclerosis, independently from bodily disability.
Methods: 79 patients with multiple sclerosis from Aalborg University Hospital, Denmark were included
in an observational, cross-sectional study. Each subject completed two separate questionnaires regarding
fatigue (Fatigue Scale for Motor and Cognitive Functions and Modified Fatigue Impact Scale) and one
regarding quality of life (Short Form 36). Disability was measured with the Expanded Disability Status
Scale (EDSS)-scores obtained from patient records.
Results: All fatigue scores were significantly correlated to all areas of quality of life (p< 0,05). This
remained significant after adjustment for age, disease duration and EDSS-score. When looking at each
type of fatigue separately, cognitive fatigue correlated mainly with mental health aspects of quality of
life and motor fatigue with physical health areas of quality of life.
Conclusion: Increased motor and cognitive fatigue lead to a differential reduction in physical and
mental quality of life, independently of bodily disability. This underlines the importance of proper
assessment and treatment of fatigue among patients with multiple sclerosis.
Keywords: Multiple sclerosis, quality of life, fatigue, motor fatigue, cognitive fatigue, EDSS
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Introduction
Multiple Sclerosis (MS) is a chronic, neurological
illness characterized by autoimmune-induced demy-
elination of nerves in CNS leading to different
degrees of disability.1 Disability status among MS
patients is most commonly measured with the
Expanded Disability Status Scale (EDSS), which
quantifies the severity of disability and is useful
for objective monitoring of disease progression,
although this tool has been criticized for its over-
emphasis on motor and gait function.2
Quality of life (QOL) measurement is an alternative
way to examine the impact of MS. QOL includes
information on several aspects of life such as overall
well-being, mental, physical and social function.3–5
MS patients have significantly reduced QOL com-
pared to the general population.2 This might be due
to onset in early years of adulthood, the unpredict-
able nature of the disease course, diffuse symptoms
and lack of proper treatment.4 Studies have shown
that this reduction in QOL can only partly be
explained by the neurological disability, pointing
out the inadequacy of disease monitoring with
EDSS-scores solitarily.2 Nonetheless, QOL is a sub-
jective measure and might not always reflect an
actual change in disease characteristics, pointing
out the need for a combination of both tools.
Fatigue is often reported as the most frequent and
disabling symptom among MS-patients, affecting up
to 80% of all patients and classified as the symptom
which interferes most with everyday life by up to
55%.1 MS-related fatigue can be categorized due
to its presentation as either motor or cognitive
fatigue, or as primary fatigue (specific to MS) or
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secondary fatigue (caused by concomitant condi-
tions).1 The pathophysiology of primary fatigue
remains unknown. Central abnormalities, inflamma-
tion and immunological factors have been found to
play a role.1 Due to the multiple types and causes of
fatigue, treatment of this symptom remains a
challenge.1
This incites the question of whether the experience
of fatigue plays a more crucial role in relation to
QOL among MS patients than physical disability
itself. Several studies have examined the relation
between overall fatigue and QOL.3,4,6,7 However, it
is now clear that unidimensional views of fatigue
and QOL are obsolete, emphasizing the need for
examining cognitive and motor fatigue, as well as
mental and physical QOL, separately.8 This will
contribute to a better understanding of the complex
nature of fatigue and the role it plays in the daily life
of MS patients, which is the first step towards
improving current treatment strategies. This has
only been examined in a few studies,9–11 pointing
towards the need for further research in this field.
The aim of this study is therefore to examine the
impact of motor and cognitive fatigue on different
aspects of QOL separately, and to investigate wheth-




We conducted an observational cross-sectional study
in accordance with the STROBE guidelines
(Supplementary material 1).9 The study population
consisted of 79 MS patients who were seen at the
MS clinic at Aalborg University Hospital in the
period from 1st November 2017 to 25th May 2018.
The inclusion criteria were: a) a diagnosis of multi-
ple sclerosis in accordance with the McDonald cri-
teria 2010;10 b) age 18 years; and c) ability to
communicate in Danish.
All study subjects completed the following three
questionnaires (Supplementary material 2), all trans-
lated to Danish.
• Fatigue Scale for Motor and Cognitive Functions,
FSMC.11
• Modified Fatigue Impact Scale, MFIS (derived
from the 40-item Fatigue Impact Scale)12
• Short Form 36, SF-36.13
The questionnaires were completed either at the hos-
pital and returned right away, or completed at home
and returned at the next appointment. EDSS-scores,
disease duration and disease course were obtained
from patient records. Latest EDSS-score (within
6months) was included, scored by a trained, blinded
neurologist.
Scales
FSMC consists of 20 items (10 for cognitive fatigue
[FSMCcog] and 10 for motor fatigue [FSMCmot])
with 1–5 points per item. The total possible score
ranges from 20–100 points. A sum score of 43 is
categorized as mild fatigue, 53 as moderate fatigue
and 63 as severe fatigue.11 The scale has under-
gone validation based on a large sample of
patients,11 and also the Danish translation has been
validated.14
MFIS consists of 21 items (9 for motor [MFISmot],
10 for cognition [MFIScog] and 2 for psychosocial
fatigue [MFISps]) with 0–4 points per item. The
total possible score ranges from 0 to 84. A score
of 38 points is categorized as fatigue.14,15 This
scale has been defined as one of the most discrimi-
native fatigue-scales.15
Both scales were examined simultaneously because
of the different aspects monitored: FSMC quantifies
fatigue itself, whereas MFIS additionally focuses on
its impact on everyday life.
SF-36 is a tool measuring perceived health status,
and is not specific for MS. The SF-36 consists of
eight dimensions (physical functioning, role limita-
tions caused by physical problems, bodily pain, gen-
eral health, vitality, social functioning, role
limitation caused by emotional problems and
mental health). Each area is individually scored
and transformed into a scale ranging from 0 (poor
health) to 100 (optimal health).13,16 SF-36 is the
most widely used generic instrument and is consid-
ered to be the golden standard in measuring health
status.4 Moreover, it is well-studied among MS-
patients,4 and has therefore been selected as the
QOL-outcome-measure. Note that while the term
quality of life may include a broad range of ele-
ments, this study restricts its focus on the health-
related area of life quality.
EDSS is a measure of disability. The score is
assessed by a clinician based on the evaluation of
eight functional systems of the CNS. It ranges from
0 (normal) to 10 (death due to MS).17 Some of the
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limitations regarding EDSS include documented
weakness in inter- and intra-rater reliability and sen-
sitivity to change. However, despite this, EDSS is
still accepted and preferred as the main disability-
outcome measure in MS.17
Statistics
Descriptive statistics were used to calculate median
age, EDSS, fatigue and QOL-scores.
Linear regression was selected as the statistical
method of data analysis. This method enabled con-
trol of confounding factors, and this was necessary
to answer the main research question raised. This
choice of method was similar to other studies in
this field.2,3,7,18,19
First, a series of simple linear regression analyses
were performed to examine the correlation between
each fatigue subscale and SF-36 subscale, respec-
tively. The correlation was quantified by Pearson’s
coefficient of correlation, r. Secondly, multiple
linear regression was performed with EDSS scores
and fatigue scores as independent values and QOL
scores as the dependent value. This was done to
examine the impact of fatigue on QOL, while adjust-
ing for EDSS. b-coefficients were found and
p-values were obtained by testing the null hypothesis
of b ¼ 0. All statistics were performed using Excel.
P-values <0,05 were considered significant.
Ethics
Written and oral consent were obtained from all par-
ticipants, and the project was approved by The North
Denmark Region Committee on Health Research
Ethics (approval no. 20170078).
Results
Demographics
79 patients who fulfilled the inclusion criteria were
identified. Median age was 44 years, median disease
duration was 9 years and median EDSS-score was
2,5. The majority of the patients (90%) had relaps-
ing remitting MS. Table 1 presents the demographic
and disease related characteristics of the study pop-
ulation at index date, including median fatigue
scores. Using the sum score cut-off points for the
FSMC, 84% of patients were fatigued (scoring
mild fatigue or more), and using MFIS, 63% were
fatigued. Median quality of life scores for each of
the eight subscales of SF-36 are listed in Table 2. All
results not shown below are summarized in
Supplementary material 3.
Table 1. Demographic and clinical features of the study population.
Total sample
N 79
Median age in years (IQR) 42 (36,5–50,8)
Gender
- Female, N (%) 60 (76)
- Male, N (%) 19 (24,)
Median EDSS (IQR) 2,5 (1,5–3,75)
Median duration of disease in years (IQR) 9 (3–13,5)
Disease course, N (%)
- Relapsing Remitting MS 71 (90)
- Secondary progressive MS 5 (6)
- Primary progressive MS 3 (4)
Median fatigue scoring (IQR)
- FSMCcog 34 (22,5–40,0)
- FSMCmot 36 (25,0–41,0)
- FSMCtot 66 (51,0–80,8)
- MFIScog 20 (13,0–24,8)
- MFISmot 19 (13,5–25)
- MFISps 3 (2,0–5,0)
- MFIStot 42 (30,5–54,8)
N, number of subjects. SD, standard deviation. FSMC, Fatigue Scale for Motor and Cognitive
Functions. MFIS, Modified Fatigue Impact Scale. _cog, cognitive subscale. _mot, motor
subscale. _ps, psychosocial subscale. _tot, total score of the scale.
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Relationship between fatigue and QOL (unadjusted)
Simple linear regression analysis was conducted for
all seven scores of fatigue and all eight scores of
QOL, respectively. They showed that all fatigue
scores (each subscores and total scores) were signif-
icantly related to all QOL-scores (p-value <0,05).
Looking at each QOL-scores, correlations with
fatigue were strongest for the questions regarding
vitality (r¼0,80 for FSMCmot), social function-
ing (r¼0,73 for MFISps) and role limitations
caused by physical problems (r¼0,70 for
MFIStot). Generally, motor fatigue scores seemed
to show a stronger correlation with QOL-
dimensions than cognitive fatigue scores.
The relationship between total fatigue score on the
FSMC-scale and QOL-scores regarding physical
functioning (PF) and mental health (MH) are
shown in Figure 1(a) and (b), respectively.
Similar analyses using the MFIS-total score are
shown in Figure 2(a) and (b).
Relationship between EDSS, age, disease duration
and QOL (unadjusted)
Disability status (EDSS) was significantly related to
all aspects of QOL except “role limitations caused
by emotional problems” (RE) and “mental health”
(MH), and showed the strongest correlation with
“physical functioning” (Figure 3(a) and (b)).
Table 2. Median quality of life score.
Median (IQR)
QOL Physical functioning (PF) 65,0 (40,0–95,0)
Role limitations caused by physical problems (RP) 25,0 (0,0–75,0)
Bodily pain (BP) 60,0 (35,0–80,0)
General health (GH) 40,0 (30,0–55,0)
Vitality (V) 35,0 (25,0–60,0)
Social functioning (SF) 62,5 (60,0–62,5)
Role limitations caused by emotional problems (RE) 66,7 (33,3–100,0)
Mental health (MH) 64,0 (48,0–76,0)
QOL, quality of life.
Figure 1. (a) Relationship between FSMCtot and Physical Functioning. FSMC, Fatigue Scale for Motor and Cognitive Functions. PF, physical
functioning. Simple linear regression analysis was used to examine the relationship between total fatigue score on FSMC and the physical
functioning dimension of QOL on SF-36. QOL decreased significantly with increasing fatigue. (b) Relationship between FSMCtot and Mental
Health. FSMC, Fatigue Scale for Motor and Cognitive Functions. MH, mental health. Simple linear regression analysis was used to examine the
relationship between total fatigue score on FSMC and the mental health dimension of QOL on SF-36. QOL decreased significantly with
increasing fatigue.
Multiple Sclerosis Journal—Experimental, Translational and Clinical
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Scores in “physical functioning” and “role limita-
tions caused by physical problems” significantly
decreased with increasing age. Furthermore, we
saw a non-significant correlation between increasing
age and better mental health.
Disease duration was only associated with “physical
functioning” and “social functioning”.
Relationship between fatigue, EDSS and QOL
(adjusted)
To evaluate the impact of fatigue and EDSS on QOL
simultaneously, multiple linear regression was per-
formed for each fatigue scale. First, total fatigue
scores and EDSS-scores were plotted in a regression
model with QOL-scores. Secondly, this was done for
Figure 2. (a) Relationship between MFIStot and Physical Functioning. MFIS, Modified Fatigue Impact Scale. PF, physical functioning. Simple
linear regression analysis was used to examine the relationship between total fatigue score on MFIS and the physical functioning dimension of
QOL on SF-36. QOL decreased significantly with increasing fatigue. (b) Relationship between MFIStot and Mental Health. MFIS, Modified
Fatigue Impact Scale. MH, mental health. Simple linear regression analysis was used to examine the relationship between total fatigue score. on
MFIS and the mental health dimension of QOL on SF-36. QOL decreased significantly with increasing fatigue.
Figure 3. (a) Relationship between EDSS and Physical Functioning. PF, physical functioning. Simple linear regression analysis was used to
examine the relationship between EDSS and the physical functioning dimension of QOL on SF-36. QOL-scores decreased significantly with
increasing EDSS. (b) Relationship between EDSS and Mental Health. MH, mental health. Simple linear regression analysis was used to examine
the relationship between EDSS and the mental health dimension of QOL on SF-36. The correlation was not significant.
David Ruban et al.
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each subscore of fatigue. Age and disease duration
were included.
Total fatigue scores, EDSS and QOL. Total fatigue
scores remained significantly associated with all
aspects of QOL after adjusting for EDSS-score.
Both scales were examined separately. EDSS corre-
lated strongly with “physical functioning” in this
analysis. However, the correlation between EDSS
and almost every other aspect of QOL, disappeared
when taking fatigue scales into account.
Fatigue subscores, EDSS and QOL. When consid-
ering the FSMC subscales separately, the motor sub-
scale correlated with all the QOL-areas related to
physical health (PF, RP, BP, GH)19 and additionally
with vitality, social functioning and mental health.
The cognitive subscale correlated exclusively with
mental health aspects (V, SF, RE, MH).19 Thus,
the two scales worked complementary to each
other and jointly covered all aspects regarding
QOL. Looking at the MFIS subscales, almost the
same pattern was seen and additionally, QOL
regarding social functioning correlated most strongly
with the psyosocial subscale (Table 3).
Discussion
This study, which examined 79 MS patients in
Denmark, showed that motor and cognitive fatigue
were significantly and differently correlated to
aspects of QOL. After adjustment for disability
status, the correlation remained significant, indicat-
ing that fatigue impacts negatively on QOL indepen-
dently of physical disability. Therefore, fatigue
assessment provides additional information to
EDSS. Supporting this statement, it was also found
that EDSS was significantly associated almost exclu-
sively with the aspect of QOL that covered physical
functioning. This indicates that not all aspects of the
disease burden are reflected in this score.
Relation to existing literature
Our results are consistent with previous studies
showing that EDSS-score is mainly related to the
physical area of QOL.2,3,5,18–21
The relation between fatigue and impaired QOL has
been found in several other studies as well. 3,4,6–
8,18,22 One recent study found a correlation between
mental QOL and cognitive fatigue, as well as phys-
ical QOL and motor fatigue, supporting our results.8
Another study found similar results but noted that
the different components of fatigue (physical,
cognitive, social role and psychological dimension)
each correlated equally with all dimensions of
QOL.22
However, some studies conclude that mental areas of
life-quality are strongly influenced by depres-
sion,7,18,23 which has not been measured in this
study (discussed later). Mental health related QOL
scores have also been found to be correlated with
work status, time since last relapse, inpatient/outpa-
tient relation and treatment.21
The relation between disease duration and QOL is
not clarified in the literature. Some studies observe a
full or partial relation,20,23 while others find none.24
The influence of age in QOL has been reported for
physical dimensions of QOL only, supporting the
results of this study.21,24
In our results, it was furthermore seen that increasing
age seemed to be correlated to better mental health
(insignificant).
The observed magnitudes of changes in QOL (for
example a reduction of 1,72 points in QOL-RP,
when motor fatigue increases by one, Table 4) is
much greater than seen in another study, where the
changes in QOL after increasement in EDSS, anxi-
ety or depression have been measured.19 All though
fatigue has not been measured in this particular
study, it speaks in favor of the anticipation that
this magnitude of change in QOL is of clinical
relevance.
Implication of central findings
Our study implicates that 1) assessment of motor and
cognitive fatigue provides us with information on
distinct areas of QOL, and 2) given this correlation,
treatment interventions targeted at reducing fatigue
might improve QOL. This is particularly important
because QOL-measurement itself has been found to
be a predictor of change in disability status over
time.25
Assessment of fatigue can be done with question-
naires, as in this study. Studies have shown that
physicians and patients have different perceptions
of disability and its impact on health, thereby point-
ing out the necessity of using patient reported out-
comes.26 Some studies have found that physicians
tend to focus on the physical parts of health, whereas
patients are more concerned about functional capac-
ity and a sense of well-being, which they are often
able to measure themselves.27
Multiple Sclerosis Journal—Experimental, Translational and Clinical
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Table 3. Relationship between EDSS, fatigue [MFIS] and Quality of Life.
EDSS MFIScog MFISmot MFISps




































































MFIS, Modified Fatigue Impact Scale; _cog, cognitive subscale; _mot, motor subscale;_PS, psychosocial subscale; _tot, total score of the
scale.
Values are expressed as b-coefficients with 95% confidence interval. They were found in an adjusted analysis, in which EDSS, fatigue, age and
disease duration were entered in a multiple linear regression analysis simultaneously. Negative b’s indicate that QOL decreases with increasing
fatigue. * p< 0,05 (p-values not shown).
Table 4. Relationship between EDSS, fatigue [FSMC] and Quality of Life.
EDSS FSMCcog FSMCmot
















































FSMC, Fatigue Scale for Motor and Cognitive Functions; _cog, cognitive subscale; _mot, motor subscale; _tot, total score of the scale.
Values are expressed as b-coefficients with 95% confidence interval. They were found in an adjusted analysis, in which EDSS, fatigue, age and
disease duration were entered in a multiple linear regression analysis simultaneously. Negative b’s indicate that QOL decreases with increasing
fatigue. * p< 0,05 (p-values not shown).
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Treatment of fatigue includes elimination of smok-
ing, reduction of caffeine intake and physical activ-
ity.28 No pharmacological agent is yet approved for
the treatment of MS fatigue, but Amantadine and
Modafinil have shown efficacy.28
The knowledge on the different impact of motor and
cognitive fatigue may prove helpful for clinicians in
predicting potential problems related to areas of
QOL among MS-patients and have implications for
the choice of treatment and care.8 For example,
mental QOL and cognitive fatigue (but not physical)
has shown to correlate to depression,7,18,23 suggest-
ing early interventions targeted at psychological
problems among this group of patients, in order to
reduce fatigue and improve QOL. Moreover,
Amantadine has shown to have a positive effect on
fatigue, but no effect on depression, which might
indicate that it is most effective on patients in
whom physical fatigue is predominant.29
Furthermore, one study found that those who were
more physically active reported lower levels fatigue,
measured on the Fatigue Severity Scale, which
addresses physical fatigue only.30 Finally, one
study found a significant correlation between unem-
ployment and cognitive, but not physical fatigue,31
which indicates the particular importance of recog-
nizing cognitive fatigue among MS patients in order
to prevent work related problems and perform appro-
priate rehabilitation services.
These differences in fatigue management and their
differential outcomes on QOL underlines the impor-
tance of measuring and being aware of both types of
fatigue separately.
Strengths and limits
The major strength of this study is that motor and
cognitive fatigue has been examined separately,
making it possible to investigate the diverse impact
on QOL.
Furthermore, MFIS has been used for fatigue assess-
ment. This scale is of particular interest because it
has been recommended by the MS Council for
Clinical Practice Guidelines based on its strong dis-
criminative properties.15
Two other studies have used this scale in a study
design similar to ours.8,22 However, these studies
did not adjust for EDSS in the analysis, pointing
out the additional information provided by our
study. Finally, two different fatigue scales have
been analyzed and showed the same pattern of
influence on aspects of QOL, supporting the corre-
lation even further.
One important limitation is that depression was not
examined in this study. Depression has shown to be
independently associated with QOL and fatigue in
several studies.3,7,16,18,22 Furthermore, fatigue may
in some cases be a symptom of depression rather
than a result of MS itself.22 However, in one cross-
sectional study examining 103 MS patients, fatigue
was found to be a predictor of QOL independent of
depression measured through the Hamilton Rating
Scale for Depression.3 Another study with prospec-
tive data collection over a 2-year period found the
same correlation, supporting our results.6 Other fac-
tors not examined include concomitant disease, med-
ications altering fatigue and sleep quality.6,7
Secondly, misclassification due to inter-observer
variation in EDSS-scoring, variance in the interval
between EDSS and fatigue/QOL scoring, and mis-
classification of fatigue due to its fluctuating nature
may occur.32 However, a recent longitudinal study
found fatigue to be independently associated with
some aspects of QOL in MS,33 supporting our
results.
The first version of the SF-36 was used instead of
the second. Version two has several improvements,
including simpler instructions and questions,
improved layout, greater comparability with other
translations and a few altered response choices.34
Despite this, the first version was used in this
study because of its well-described and well-
studied status in a Danish context.35
Finally, the cross-sectional design of this study
makes us unable to prove a causal relationship
between fatigue and reduced QOL.
The external validity of the study is threatened by
the fact that our study population is only mildly dis-
abled (EDSS 2,5), are from the same geographical
place and mostly consist of patients with RRMS.
However, the number of studies with the same find-
ings, supports the validity.
Conclusion
This study shows that motor and cognitive fatigue is
significantly and differentially correlated to reduced
QOL, independently of bodily disability. This under-
lines the need for proper assessment of fatigue
through the use of subjective, patient-reported meas-
ures, in order to get a holistic view of the disease
Multiple Sclerosis Journal—Experimental, Translational and Clinical
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impact, which builds the foundation for development
of appropriate and specific treatment interventions.
These findings encourage further research in the
field.
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